Biocon Limited has scheduled a board meeting on February 12, 2026, to approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). An earnings conference call for analysts and investors will be held on February 13, 2026, at 09:00 hrs IST. Details for registration and access to the call recordings are available on Biocon’s website.
Q3 Financial Results and Board Meeting
Biocon Limited will hold a board meeting on Thursday, February 12, 2026, to review and approve the unaudited standalone and consolidated financial results for Q3 FY26, which covers the quarter and nine months ending December 31, 2025. The announcement was officially made on January 13, 2026.
Earnings Conference Call Details
An earnings conference call for analysts and investors is scheduled for Friday, February 13, 2026, at 09:00 hrs IST. The call will follow the financial results announcement and will be conducted via Zoom. Registration is required, and a link has been provided for interested participants.
Recording Availability
Audio recordings of the conference call will be available before the next trading day, or within 24 hours after the call’s conclusion. Video recordings will be available within 48 hours. Both recordings will be accessible via the company’s investor relations section of their website under Financial Information > Earnings Call Recordings.
Trading Window Closure
As per the company’s insider trading regulations, the trading window for dealing in the company’s securities has been closed from January 1, 2026, and will remain closed until February 14, 2026. It will reopen on Sunday, February 15, 2026.
Source: BSE
